Business Wire

AgroAmerica Presents Its 2022 Sustainability Report: A Future Built to Last

18.7.2023 17:12:00 EEST | Business Wire | Press release

Share

AgroAmerica presented its ninth Sustainability Report. This report provides an updated overview of the performance of the company’s banana division and the achievements made in 2022 through its Corporate Sustainability Strategy.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230717281841/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

AgroAmerica's sustainability report details the structure, governance, strategy, and management of the company, with a specific focus on the material issues identified. Over the past year, AgroAmerica has worked on environmental, social, and governance topics that are relevant to the business. (Photo: Business Wire)

"We are pleased to announce that the year 2022 marks the final chapter of our current strategy, as well as the starting point of a significant transformation. In this process, our strong foundation in sustainability will drive a new robust integrated strategy that will shape our path in 2023-24. This exciting step will lead us to continuous improvement and a more sustainable future," explained Fernando Bolaños, CEO of AgroAmerica.

Using a regenerative approach, the company undertakes actions aimed at promoting soil health, resource conservation, biodiversity preservation, and the reduction of carbon emissions. As part of this strategy, AgroAmerica has initiated a project, unique in the region, that protects bees and other pollinators in forest conservation areas located in our operations.

Some of the highlighted achievements included in this report:

  • The installation of a macro sanctuary to house and protect more than 30,000 native bees and pollinators.
  • Receiving the "2022 Conservation Leadership Award" from the RSPO Excellence Awards to the Mayan Biosphere conservation project.
  • Receiving the "Grand Prize in Business Sustainability" from the American Chamber of Commerce for our "Mangrove Ecosystem Restoration Project" on the Pacific Coast of Guatemala.
  • Obtaining the “RSPO certification” in our operations in Panama, meaning that all the operations of the tropical oil division in AgroAmerica are now certified.
  • The generation of over 12,000 direct and indirect jobs that promote gender equality and development opportunities for our employees, their families and our neighboring communities.
  • Contributing to 11 of the United Nations’ Sustainable Development Goals.
  • Holding 11 international certifications related to good practices, sustainable operations, and food quality and safety.
  • The conservation of more than 970 hectares of forests in areas within our company’s operations.

"We are a world-class corporation that adapts to global market challenges to exceed environmental, governance and social expectations and offer high-value-added products to the world," stated Javier Aguirre, Corporate Director.

This report shows our path forward with a renewed focus on sustainability, and reaffirms our company's commitment to the environment, society, and governance in the production of high-quality sustainable food.

See full report here.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Susana Perez
Communications and Public Relations Coordinator
sperez@agroamerica.com
(+502) 5554-8774

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 21:00:00 EEST | Press release

Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro

Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release

Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o

Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release

Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a

DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye